The Traderszone Network

Published in TZ Latest News 14 October, 2014 by The TZ Newswire Staff

J&J sales top forecast, helped by drug for hepatitis C

Johnson & Johnson reported strong quarterly earnings, boosted by surging sales of a new drug for hepatitis C that are expected to evaporate in coming months due to competition from a more potent and convenient …